Entela Xoxi
Senior Scientific Advisor, Independent Consultant
Entela Xoxi is listed as Senior Scientific Advisor, Independent Consultant. Entela spoke at ISPOR Europe 2026 in November 2026 (speaker, “Can We STEDI the Course? Antimicrobial Value Assessment at a Crossroads”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Entela. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Pharmacologist with extensive experience in product-based registries, gained over ten years at the Italian Medicines Agency (AIFA), where I contributed to the design, conceptual development and implementation of the current AIFA Registries platform, and served for three years as Coordinator of AIFA Registries. The expertise covers Regulatory affairs, Health Technology Assessment and Market Access, with a specific focus on real-world data generation and analysis, Managed Entry Agreements, and the assessment of innovativeness within pricing and reimbursement dossiers. This includes the evaluation of therapeutic need and added therapeutic value under the AIFA framework, performed in close collaboration with statisticians to ensure a robust appraisal of the quality and interpretability of the clinical evidence.
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Can We STEDI the Course? Antimicrobial Value Assessment at a Crossroads Speaker · 11 November 2026
Spoke alongside
People who have shared a session with Entela at events on B2DB.
- Grace Hampson Director · Office of Health Economics 1 shared session
- Edward I Broughton Pfizer 1 shared session
- Laith Yakob Senior Technical Director · Adelphi Values 1 shared session
Others from Independent Consultant
- Brit Blakeney-Anghelakis Principal Consultant, Digital Strategy 4 sessions
- Dinesh Arora Marketing Head - Fractional 2 sessions
- John Hearne 1 session